Live

Stocks are getting hit again as Trump lashes out at the Fed and Powell. See the latest.

Berlin - Delayed Quote EUR

Therma Bright Inc (JNX.BE)

Compare

0.0140

0.0000

(0.00%)

At close: April 17 at 7:31:05 PM GMT+2

Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes

Toronto, Ontario--(Newsfile Corp. - April 16, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to provide an update to address the potential impact of recent and evolving US tariff policies on our current manufacturing operations of Venowave in China, which serves the US market.The Company is actively reviewing the implications of recent

Newsfile 5 days ago

TBRIF
+2.92%
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC

National Distributor to Sell Cold Sore Prevention Device Through National Ecommerce Sales Through Direct to Consumer Marketing Efforts Toronto, Ontario--(Newsfile Corp. - March 13, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that the Company has secured an exclusive U.S. contract for its consumer product devices with nat

Newsfile last month

TBRIF
+2.92%
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board

Announces Shares for Debt Settlements Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the addition of Steve Raysely to its Advisory Board. With deep experience in healthcare and technology sales, marketing and operations, Mr. Raysely brings a wealth of expertise to the Company's growing advisory team.

Newsfile 2 months ago

TBRIF
+2.92%
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN

National Distributor Eager To Begin Sales & Marketing Of Vascular Compression Therapy Solutions Toronto, Ontario--(Newsfile Corp. - January 21, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that it has secured a purchase order for 1,750 Venowave VW5 from national distribution partner DME Authority of Nashville, Tennessee.

Newsfile 2 months ago

TBRIF
+2.92%
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio

National Distributor And Its Network Receive Upwards Of 100 Doctor Referrals Per Day For Vascular Compression Therapy Solutions Toronto, Ontario--(Newsfile Corp. - January 13, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that the Company has secured an initial purchase order for 100 Venowave VW5 units from a new national

Newsfile 3 months ago

TBRIF
+2.92%
Therma Bright Announces Shares for Debt Issuance

Toronto, Ontario--(Newsfile Corp. - January 9, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces that the Company has negotiated a debt settlement with arm's length creditor. Pursuant to the debt settlement it has arranged, and subject to acceptance by the TSXV, the Company proposes to settle aggregate debt of ...

Newsfile 3 months ago

TBRIF
+2.92%
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority

Initiative Includes Milestone-Based Inventory Purchase Commitments During Q1 and Q2, 2025 Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce the Company has signed a letter of intent (LOI) for a Venowave distribution program with DME Authority based in Nashville, TN. Through this

Newsfile 4 months ago

TBRIF
+2.92%
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase

Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London. Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, congratulates its investment partner Inretio on the success of the first phase of the PREVA™ ischemic stroke device. Per Inretio's LinkedIn post and formal

Newsfile 4 months ago

TBRIF
+2.92%
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days

Distributors' medical partner networks impressed with Venowave device, speed of Medicare/Medicaid processing and prepare roadmaps to drive salesToronto, Ontario--(Newsfile Corp. - December 5, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that its nationwide U.S. distribution partners, along with several prospective new par

Newsfile 4 months ago

TBRIF
+2.92%
Therma Bright Full Year 2024 Earnings: CA$0.008 loss per share (vs CA$0.016 loss in FY 2023)

Therma Bright ( CVE:THRM ) Full Year 2024 Results Key Financial Results Net loss: CA$2.45m (loss narrowed by 35% from...

Simply Wall St. 4 months ago

TBRIF
+2.92%
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies

Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologies, has completed its announced strategic review, and has set the course to spin-off the Company's Consumer Product Portfolio into its own separate publicly traded company. This move is aimed at strengthening Therma Bright's strategic and operational focus, capitalizing on growth opportunities, and

Newsfile 4 months ago

TBRIF
+2.92%
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions

InStatin to secure exclusive worldwide licensing agreement of InVixa's inhaled statin solution to prevent and treat acute lung disease Toronto, Ontario--(Newsfile Corp. - October 28, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce a significant development with its investment partners, InStatin and InVixa. InVixa will assign its licensing agreement to InStatin, contin

Newsfile 5 months ago

TBRIF
+2.92%
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release

Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement Test Therma Bright Closes First Tranche of Non-Brokered Concurrent Private Placement for CAD $174,900Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that its na

Newsfile 6 months ago

TBRIF
+2.92%
Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million

LIFE Financing and Concurrent Private Placement to Include Common Shares Only and no Warrants Toronto, Ontario--(Newsfile Corp. - September 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that it will be conducting a non-brokered listed issuer financing exemption (LIFE) private placement of up to CAD$3,00

Newsfile 6 months ago

TBRIF
+2.92%
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement

Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human Trials. Toronto, Ontario--(Newsfile Corp. - September 23, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in cutting-edge diagnostic and medical device technologies, extends its congratulations to strategic investment portfolio company InStatin on its recent agreement with Mountain Wes

Newsfile 6 months ago

TBRIF
+2.92%
Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement

Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces that AI4LYF has agreed to participate in a shares for debt transaction which progresses the Company's contractual obligation to AI4LYF while preserving cash.Therma Bright is the global exclusive license holder of the innovati

Newsfile 6 months ago

TBRIF
+2.92%
Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board

New Advisory Board Member will focus on Venowave sales and business development efforts Toronto, Ontario--(Newsfile Corp. - September 12, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the addition of Douglas S. Sommerville to its Advisory Board. With 30 years of experience in sales and operations within the medical device industry, Mr. Sommervill

Newsfile 7 months ago

TBRIF
+2.92%
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award

Chairman of Therma Bright's Strategic Investment Partner Recognized for Outstanding Research and Discovery in Respiratory Drug Delivery Toronto, Ontario--(Newsfile Corp. - September 4, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in cutting-edge diagnostic and medical device technologies, extends its congratulations to strategic investment partner InStatin's John Patton, Ph.D on receiving the prestigious Charles G. Thiel A

Newsfile 7 months ago

TBRIF
+2.92%
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success

Game-Changing Innovation Poised to Transform Stroke and Blood Clot TreatmentTherma Bright's Strategic Investment Helps Medical Device Company Demonstrate Efficacy and Safety in Transforming Ischemic Stroke CareToronto, Ontario--(Newsfile Corp. - August 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is thrilled to announce

Newsfile 7 months ago

TBRIF
+2.92%
RETRANSMISSION: Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave

Nationwide partner launches initial Venowave sales program to gauge Medicare/Medicaid reimbursement timelines and billing procedures Post initial program success, distributor commits to acquire remaining inventory that totals up to USD $2.38M in reimbursement valueToronto, Ontario--(Newsfile Corp. - August 23, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic an

Newsfile 7 months ago

TBRIF
+2.92%

Performance Overview

Return	JNX.BE	S&P/TSX Composite index (^GSPTSE)
YTD	-30.00%	-2.94%
1-Year	+86.67%	+9.58%
3-Year	-90.79%	+10.38%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

Therma Bright Inc (JNX.BE)

Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes

Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC

Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board

Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN

Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio

Therma Bright Announces Shares for Debt Issuance

Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority

Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase

Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days

Therma Bright Full Year 2024 Earnings: CA$0.008 loss per share (vs CA$0.016 loss in FY 2023)

Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies

Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions

Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release

Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million

Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement

Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement

Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board

Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award

Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success

RETRANSMISSION: Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave

Performance Overview